🔗 Share this article

The top legal official in Texas Ken Paxton is suing the makers of acetaminophen, alleging the companies withheld alleged dangers that the medication presented to pediatric neurological development.

This legal action arrives a month after President Donald Trump promoted an unverified association between using Tylenol - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in young ones.

Paxton is filing suit against Johnson & Johnson, which once produced the medication, the exclusive pain medication approved for expectant mothers, and the current manufacturer, which currently produces it.

In a statement, he stated they "misled consumers by gaining financially from pain and marketing drugs regardless of the potential hazards."

The manufacturer says there is lacking scientific proof tying Tylenol to autism.

"These corporations lied for decades, intentionally threatening countless individuals to line their pockets," the attorney general, from the Republican party, said.

The manufacturer said in a statement that it was "very worried by the perpetuation of misinformation on the security of paracetamol and the possible consequences that could have on the well-being of American women and children."

On its official site, Kenvue also said it had "consistently assessed the relevant science and there is no credible data that indicates a established connection between taking paracetamol and autism spectrum disorder."

Organizations acting on behalf of medical professionals and healthcare providers agree.

ACOG has declared paracetamol - the key substance in Tylenol - is a restricted selection for women during pregnancy to manage discomfort and elevated temperature, which can create serious health risks if left untreated.

"In more than two decades of studies on the use of paracetamol in pregnancy, not a single reputable study has conclusively proven that the use of acetaminophen in any stage of pregnancy leads to neurodevelopmental disorders in young ones," the organization stated.

This legal action references current declarations from the previous government in asserting the medication is potentially dangerous.

Last month, Trump raised alarms from medical authorities when he instructed women during pregnancy to "struggle intensely" not to use acetaminophen when sick.

The FDA then released a statement that physicians should consider limiting the usage of Tylenol, while also mentioning that "a causal relationship" between the medication and autism in minors has not been established.

Health Secretary Kennedy, who manages the Food and Drug Administration, had promised in April to undertake "comprehensive study program" that would identify the cause of autism in a limited time.

But authorities advised that finding a single cause of autism spectrum disorder - believed by scientists to be the consequence of a complex mix of genetic and environmental factors - would prove challenging.

Autism is a type of enduring cognitive variation and condition that impacts how people encounter and interact with the environment, and is identified using medical professional evaluations.

In his legal document, the attorney general - who supports Trump who is seeking federal office - claims the manufacturer and J&J "deliberately disregarded and sought to suppress the research" around acetaminophen and autism.

The lawsuit seeks to make the firms "destroy any commercial messaging" that asserts Tylenol is reliable for women during pregnancy.

The Texas lawsuit parallels the complaints of a assembly of mothers and fathers of children with autism and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in 2022.

The court dismissed the lawsuit, declaring research from the family's specialists was not conclusive.